Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Bortezomib chemotherapy can cause temporary skin rashes.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

FDG PET/CT can improve cancer treatment plans in dogs.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

MK-5108 is safe and shows potential against tumors, especially alone.

Cancer prevention has advanced significantly, with some strategies proving successful.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.